In today’s news: hundreds rally against ICE in Carrboro, and environmental advocates pan proposed new state rules for “forever” chemicals. Also: UNC students raise concerns about living conditions in Granville Towers; UNC men’s basketball gets its 500th win in the Smith Center; Tar Heel women’s basketball falls at Notre Dame; Carolina gymnastics, swimming & diving, fencing, and women’s tennis all score weekend wins; and the transfer portal remains open for UNC football, while the Tar Heels officially confirm Bobby Petrino as their next offensive coordinator.
97.9 The Hill WCHL and Chapelboro.com are your headquarters for local news in Chapel Hill-Carrboro. Every weekday morning, 97.9 The Hill’s Aaron Keck recaps the day’s news, from local government to business developments to UNC sports. Click here to listen back to all of Aaron’s daily news reports, which you can hear live during “This Morning with Aaron Keck” every weekday from 6:00 to 9:00 a.m.
You can also listen to “This Morning with Aaron Keck” on Spotify. Click here to follow Aaron and listen to all his segments, from local news to fun features to hard-hitting interviews.
Listen:
The Morning News: Anti-ICE Protest, Forever Chemicals, 500 Smith Center Wins Chapelboro.com.
Hence then, the article about the morning news anti ice protest forever chemicals 500 smith center wins was published today ( ) and is available on chapelboro ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Morning News: Anti-ICE Protest, Forever Chemicals, 500 Smith Center Wins )
Also on site :
- commercetools Kicks Off NRF 2026 - including Updates on Stripe ACS, AI Hub, and Helping Enterprises Stay Discoverable and Shoppable in Agentic Commerce
- inDrive turns to ads and groceries to diversify revenue
- Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates